Pharmacy Foundations 1 Flashcards
what happens with chelation and what drugs do you want to separate from them?
-occurs when a drug binds to polyvalent cations (Mg++, Ca, Fe++) in another compound (antacids or iron supplements) –> passes thru the stool
-quinolones, trtracyclines, levothyroxine, and oral bisphosphonates
pharmacodynamics
the effect that a drug has on the body. the effect can be therapeutic or toxic
pharmacokinetics
the effect the body has on the drug as it goes through the ADMW processes
if gastrointestinal pH is Increased, aborportion will be _______
decreased
ex: H2RAs, PPIs (acidic) taken with itraconazole decrease the funtion of the antifungal and can lead to resistant infections
what are the prodrug and active metabolite pairings:
1) Capecitabine:
2) Clopidogrel:
3) Codeine:
4) Colistimethate:
5) Cortisone:
1) Fluorouracil
2) active metabolite
3) morphine
4) colistin
5) cortisol
what are the prodrug and active metabolite pairings:
6) Famciclovir:
7) Fosphenytoin:
8) Isavuconazonium sulfate:
9) Levadopa:
10) Lisdexametamine:
6) Penciclovir
7) Phenytoin
8) Isavuconazole
9) Dopamine
10) Dextroamphetamine
what are the prodrug and active metabolite pairings:
11) Prednisone:
12) Primidone:
13) Tramadol:
14) Valacyclovir:
15) Valganciclovir:
11) Prednisolone
12) Phenobarbital
13) active metabolite
14) Acyclovir
15) Ganciclovir
what effect do CYP enzyme inhibitors have?
DECREASE enzyme function and the ability to metabolize compounds
substrates: decrease the rate of metabolism = INCREASED serum drug levels
what are common CYP inhibitors involved in drug interactions? (G <3 PACMAN)
G: grapefruit
P: protease inhibitors (ritonavir)
A: Azole antifungals (fluconazole, itraconazole, ketoconazole, posaconazole, voriconazole, and isvuconazonium)
C: cyclosporine, cobicistat
A: amiodarone and drondarone
N: non-DHP CCBs: diltiazam, verapamil
What effect to CYP enzyme inducers have?
increase enzyme production or activity
-substrates for the enzyme will have an INCREASED rate of drug metabolism = DECREASED serum drug level
-actions: increase dose of substratecomm
Common CPY inducers involved in drug interactions: (PS PORCS)
P: phenytoin
S: smoking
P: phenobarbital
O: oxacarbazepine
R: rafampin, rifabutin, rifapentine
C: carbamazepine (also an auto-inducer)
S: st. johns wort
what are P-gp efflux pumps?
loacted in many tissue membranes where they protect against foreign substances by moving them out of critical aread
-pump out of the bod by pumping them into the gut, where they can be excreted in the stool
Common P-gp substrates:
-anticoagulants (apixaban, rivaroxaban)
-cardio drugs (digioxin, diltiazam, verapamil)
-immunosuppressants (cyclosporine, tacrolimus)
-HCV drugs: sofosbuvir
-others: (colchicine)
Common P-gp inducers:
-carbamazepine
-phenobarbital
-phenytoin
-rifampin
-St. John’s wort
Common P-gp inhibitors:
-anti-infection: clarithromycin, itraconazole, posaconazole
-cardio drugs: amiodarone, diltiazam, verapamil
-HIV drugs: cobicistat, ritonavir
-HCV drugs: ledipasvir
-others: cyclosporine
what is enterohepatic recycling?
-the recycling of a already metabolized drug- increases the duration of action of amny drugs, including some abx, NSAIDs and ezetimibe
DDI: amiodarone and warfarin
-can be used together for afib
-amiodarone inhibits multiple enzymes, including CYP2C9, which metabolizes the more potent warfarin isomer
–> dec warfarin metabolism = inc INR and bleed risk
-want to dec warfarin dose and monitor INR
DDI: amiodarine and digoxin
-can be used together for afib
-amiodarone inhibits P-gp: digoxin is a P-gp substrate –> dec digixon excretion = inc ADRs/toxicity
-both drugs: inc risk of bradycardia, arrhythmia, fatality
–> dec digixon dose by 50% if used together and monitor HR
DDI: Digoxin and loop diuretics
-can be used for HF tx
-loop diuretics dec K, Mg, Ca, Na = can worsen arrhythmias
–> digoxin toxicity risk is increased with less K, Mg and inc Ca level
(renal impairment: dec digoxin dose, freq or d/c drug)
DDI: statins and strong CYP3A4 inhibitors
-inhibitors = ritonavir, cobicistat, clarithromycin, erythromycin, azole antifungals, cyclosporine, grapefruit
-inc levels of lovastatin, simvastatin, atorvastatin = inc myopathy risk, can cause rhabdomyolysis with ARF
–> simvastatin and lovastatin are CI with strong CYP3A4 inhibitors: can use pitavastain, pravastatin, rosuvastatin
DDI: warfarin and CYP2C9 inhibitors and inducers
-inhibitors: azoles, sulfamethoxazole/trimethoprim, amiodarone, metronidazole –> INC level of warfarin
-inducers: rifampin, St. John’s wort –> DEC levels of warfarin
DDI: CYP3A4 inhibitors and CYP3A4 substrates (opioids, fentanyl, hydrocodone, oxycodone, methadone)
-dec CYP3A4 substrate metabolism will cause INC drug levels, and INC ADRs/toxicity
DDI: Valproate and lamotrigine
-valproate DEC lamotrigine metabolism and INC lamotrigine levels causing inc risk of skin reactions: SJS/TEN
DDI: MAOIs and drugs/foods that inc sertonin, epi, NE and DA
do NOT use together
-use a 2 week washout period when switching between drugs with MAOI inhibition or serotonergic properties (wait 5 weeks for FLUOXETINE)
-avoid tyramine rich foods: wine, ages cheese, dry meats
DDI: CYP2D6 inhibitors (amiodarone, fluoxetine, paroxetine, fluvoxamine) and CYP2D6 substrates (codeine, meperidine, tramadol, tamoxifen)
-dec drug substrate metabolism
-inc ADRs/toxicity
avoid using together is possible
DDI: CYP3A4, P-GP inhibitors and CNIs (tacrolimus, cyclosporin)/ mTOR kinase inhibitors (sirolimus, everolimus)
-DEC drug substrate metabolism = inc ADR/toxicity, inc BP, nephrotoxicity, metabolic syndrome etc
-avoid using together
DDI: antiepeliptic drugs CYP inducers and other drugs metabolized by CYP enzymes (BC)
-INC substrate (drug) metabolism will cause DEC drug levels
-dec drug effect with AEDs = loss of seizure control
-monitor drug levels
-if lamotrigine, use starter kit with higher levels first
DDI:Rifampin and CYP/P-gp substrates
concentration of substrate drugs will greatly decrease
DDI: CYP3A4 inducers and opioids that are CYP3A4 substrates (fentanyl, hydrocodone, oxycodone, methadone)
-inc metabolism = DEC opioid concentration –> analgesia relief will decrease
DDI: CYP3A4, P-gp inducers and CNIs/mTORs
-inc drug metabolism = dec transplant drug level and inc risk of transplant/organ rejection
DDI: Smoking and some antipsychotics, antidepreaasants, hypnotics, anxiolytics, caffeine, theophylline, warfarin (R-isomer)
-smoker who quit: when cig is stopped, drug concentrations of CYP1A2 substrates with inc = toxicity
-current smoker: CYP1A2 substrate will have dec levels
What drugs can cause serotonergic toxicity? (6 classes)
- antidepressants: SSRIs, SNRIs, TCAs, mirtazapine, trazodone
- MAOis
-opioids
-triptans
-natural products: St. John’s wort, L-tryptophan
-others: buspirone, lithium, dexatromethorphan
what are the risks of serotonergic toxicity?
-autonomic dysfunction: diaphoresis, N/V, hyperthermia
-AMS (akathesia, anxiety, agitation, delirum)
-neuromuscular excitation (hyperreflexia, tremor, regidity, tonic-clonic seizures)
–> avoid using serotonergic drugs together- 2 week wash out or 5 weeks with flouxetine
what drugs cal increase bleeding risk? (5 classes)
-anticoagulants (warfarin, DOACs, heprin, fondaparinux)
-antiplatelets (aspirin, clopidogrel, prasagrul, ticagular)
-NSAIDs (ibuprofen, naproxen, dicofenac, indomethacin)
-SSRI/SNRIs (citalopram, ecitalopram, fluuxetine, sertraline etc)
-Natural products (5 Gs: garlic, ginger, ginkgo biloba, ginseng, glucosamine)
what drugs increase the risk of hyperkalemia? (3 classes)
-RAAS drugs (ACE, ARBBs, aliskiren, entresto, spirinolactone, eplerenone)
-Potassium-sparing diuretics (amiloride, triamterene)
-others (KCL, CNIs, bactrim, canagliflozin)
what drugs can cause QT Prolongation? (7 classes)
-antiarrhythmics
-anti-infectives (antimalaria, azoles, lefamulin, macrolides, quinolones)
-antidepressants (SSRIs- citalopram and ecitalopram, TCAs, mirtazapine, trazodone, venlafaxine)
-antipsychotics (haloperidol, thioridazine)
-antiemetics (ondansetron, droperidol, metoclopramide, promethazine)
-oncology: (leuprolide, nilotinib, oxaliplatin)
-others: (cilostazol, donepezil, fingolimod, hydroxyzine, loperamide, methadone, tacrolimus)
what drugs can cause ototoxicity? (5 classes)
-animoglycosides (gentamicin, tobramycin, amikacin)
-cisplatin
-loop diuretics -esp rapid IV injection (furosemide, bumetanide, ethacryinic acid)
-salicylates (aspirin, salslate, magnesium salicylate)
-vancomycin
what drugs can cause nephrotoxicity? (6 classes)
-anti-infectives (aminoglycodies, amphotericin B, polymyxines, vancomycin)
-cisplantin (use amifostine (ethyol) to protect kidneys)
-calcineurin inhibitors (cyclosporine, tacrolimus)
-loop diuretics (furosemide, torsemide, bumetanide, ethacrynic acid)
-NSAIDS
-radiographic-contrast dye
what drugs are anticholinergic? (6 classes)
-antidepressants/antispychotics (paroxetine, TCAs, 1st gen antipsy)
-sedating antihistamines (diphenhydramine, brompheniramine, doxylamine, hydroxyxine, meclizine)
-centrally acting anticholinergics (benztropine, trihexyphenidyl)
-muscle relaxants (baclofen, carisoprodol, cyclobenzaprine)
-antimuscarinics (oxybutynin, darifenacin, tolterodine)
-others (atropine, belladonna, dicyclomine)
what drug classes interact with PDE-5 inhibitors (sildenafil, tadalafil, avanafil, vardenafil) to cause hypotension/orthostasis?
-CYP3A4 inhibitors
-nitrates
-alpha-1 blockers (non-selective: doxazosin, terazosin) or selective: tamsulosin)
Common CYP3A4 substrates (8 classes)
-analgesics: fentanyl, hydrocodone, methadone, oxycodone
-anticoagulants: apixaban, rivaroxaban, R-warfarin
-cardiovascular drugs: amiodarone, amlodipine, diltiazem, verapamil
-immunosuppressants: cyclosporine, tacrolumus, sirolimus
-statins: atorvastatin, lovastatin, simvastatin (ALS)
-HIV drugs: NNRTIs
-PDE-5 inhibitors: avanafil, sildanafil, tadalafil, vardenafil
-others: ethinyl
Common CYP3A4 inducers
-carbmazepine
-oxacarbazepine
-phenobarbital
-phenytoin
-rifampin
-smoking
-St. John’s Wort
Common CYP3A4 inhibitors (4 classes)
-anti-infectives: clarithromycin, erythromycin, azoles, isoniazid
-cardio drugs: amiodarone, diltiazam, verapamil
-HIV drugs: cobicistat, ritonavir, protease inhibitors)
-others: cyclosporine, grapefruit,
common CYP1A2 substrates
-theophylline
-R-warfarin
common CYP1A2 inducers
-carbamazepine
-phenobarbital
-phenytoin
-rifampin
-smoking
-St. john’s wort
common CYP1A2 inhibitors
-ciprofloxacin
-fluvoxamine
common CYP2C8 substrates
-amiodarone
-pioglatazone
-repaglinide
common CYP2C8 inducers
-phenytoin
-rifampin
common CYP2C8 inhibitors
-amiodarone
-clopidogrel
-bactrim
common CYP2C9 substrates
-S-warfarin
common CYP2C9 inducers
-carbamazepine
-phenobarbital
-phenytoin
-rifampin
-smoking
-St. John’s wort
common CYP2C9 inhibitors
-amiodarone
-fluconazole
-metronidazole
-bactrim
common CYP2C19 substrates
-clopidogrel
common CYP2C19 inducers
-carbamazepine
-phenobarbital
-phenytoin
-rifampin
common CYP2C19 inhibitors
-esomerprazole
-omerprazole
common CYP2D6 substrates (3 classes)
-analgesics: codeine, meperidine, tramadol
-antipsychotics/antidepressants
-others: tamoxifen
Common reference range: Calcium (Ca)
8.5-10.5 mg/dL
calculate corrected calcium if albumin is low
- can be increased due to calcium supps, vitamin D, thiazides diuretics
- can be dec due to long term heparin, loop diuretics, bisphosphonates, cincacalcet
–> supp Ca in preganany, osteo and with certain drugs
Common reference range: Magnesium (Mg)
1.3-2.1 mEq/L
- can be inc due to mag containing antacids and laxatives
- can be dec due to PPI, diuretics, amphotericin B, diarrhea and chronic alcohol intake
Common reference range: Phosphate (PO4)
2.3-4.7 mEq/L
- inc in CDK
-dec due to phosphate binders, foscarnet, oral calcium intake
Common reference range: Potassium (K)
3.5-5 mEq/L
-inc due to ACEi, ARB, aldosterone receptor agonists, aliskiren, canagloflozin, cyclosporine, tacrolimus, potassium supps, bactrim
-dec due to beta 2 agonists, diuretics, insulin, sodium polystyrene, sulfonate
Common reference range: Sodium (Na)
135-145 mEq/L
-inc due to hypertonic saline, tolvaptan
-dec due to carbamazepine, oxacarbazepine, SSRIs, diuretics
Common reference range: Bicarbonate (HCO3)
V: 24-30 A: 22-26 mEq/L (used to assess acid-base status
-inc due to loop diuretics, systemic steroids
-dec due to topiramate, salicylate overdose